Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C18H24Cl3O2.Na |
| Molecular Weight | 401.731 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].[O-]C(=O)C(Cl)(Cl)CCCCCCCCCCC1=CC=C(Cl)C=C1
InChI
InChIKey=QZQFJPRNYPFYID-UHFFFAOYSA-M
InChI=1S/C18H25Cl3O2.Na/c19-16-12-10-15(11-13-16)9-7-5-3-1-2-4-6-8-14-18(20,21)17(22)23;/h10-13H,1-9,14H2,(H,22,23);/q;+1/p-1
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| BM 17.0744: a structurally new antidiabetic compound with insulin-sensitizing and lipid-lowering activity. | 1999 Jan |
|
| Peroxisome proliferator-activated receptor-alpha ligands inhibit cardiac lipoprotein lipase activity. | 2001 Aug |
|
| Human adipocyte fatty acid-binding protein (aP2) gene promoter-driven reporter assay discriminates nonlipogenic peroxisome proliferator-activated receptor gamma ligands. | 2004 Nov |
|
| Drug evaluation: K-111, an insulin-sensitizing peroxisome proliferator-activated receptor alpha agonist. | 2007 Apr |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
23689862
Created by
admin on Fri Dec 15 15:54:54 GMT 2023 , Edited by admin on Fri Dec 15 15:54:54 GMT 2023
|
PRIMARY | |||
|
178671-17-5
Created by
admin on Fri Dec 15 15:54:54 GMT 2023 , Edited by admin on Fri Dec 15 15:54:54 GMT 2023
|
PRIMARY | |||
|
E6LJ4G8ULV
Created by
admin on Fri Dec 15 15:54:54 GMT 2023 , Edited by admin on Fri Dec 15 15:54:54 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD
